Nanoscale Delivery Leverage Keystone Nano’s NanoJackets and Nanoliposomes to position our capabilities as advanced drug delivery and targeted therapy solutions for oncology partners and biotech companies seeking improved intracellular delivery and customizable release profiles.

Co-development Growth Target pharmaceutical and biotech firms seeking co-development partnerships to accelerate commercialization of nanotechnology-enabled therapeutics, highlighting their internal programs and external collaboration model as a differentiator.

Biocompatible Advantage Emphasize the biocompatible, non-toxic, cell-dissolving properties of NanoJackets to address safety and regulatory concerns for potential customers pursuing nanoparticle-based formulations and combination therapies.

Cancer Focus Capitalize on demonstrated relevance to melanoma, breast cancer, and leukemia through Nanoliposomes to target oncology customers with pipeline fit, potential for ceramide delivery, and scalable liposome manufacturing capabilities.

Strategic Partnerships Position Keystone Nano as a collaborative partner for large pharma and mid-size biotechs with a lightweight team and revenue in the low millions, offering a flexible, partner-friendly development timeline and access to unique nanomaterial platforms.